Treatment as the Best Prevention: Twice-Yearly Lenacapavir, a Game Changer in Ending the AIDS Epidemic

Ziyu Wen; Minjuan Shi; Caijun Sun

doi:10.3390/v16091368

Treatment as the Best Prevention: Twice-Yearly Lenacapavir, a Game Changer in Ending the AIDS Epidemic

Viruses. 2024 Aug 28;16(9):1368. doi: 10.3390/v16091368.

Authors

Ziyu Wen¹, Minjuan Shi¹, Caijun Sun^{1

2

3

4}

Affiliations

¹ School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
² Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety, Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
³ Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou 510080, China.
⁴ State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.

Abstract

Despite over four decades of unremitting efforts since the discovery of acquired immunodeficiency syndrome (AIDS)/human immunodeficiency virus (HIV), there remains no cure for HIV nor a vaccine for its prevention [...].

Publication types

Editorial

MeSH terms

Acquired Immunodeficiency Syndrome* / drug therapy
Acquired Immunodeficiency Syndrome* / epidemiology
Acquired Immunodeficiency Syndrome* / prevention & control
Anti-HIV Agents* / administration & dosage
Anti-HIV Agents* / therapeutic use
Epidemics / prevention & control
HIV Infections / drug therapy
HIV Infections / epidemiology
HIV Infections / prevention & control
Humans

Substances

Anti-HIV Agents

Grants and funding

This research was funded by the National Natural Science Foundation of China (82271786, 82472267), Science and Technology Planning Project of Guangdong Province, China (2021B1212040017), Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety (ZDSYS20230626091203007), the Sanming Project of Medicine in Shenzhen Nanshan (No. SZSM202103008), and the Key Subject of Nanshan district of Shenzhen for AIDS surveillance and prevention.